ALNY Covered Call Analysis: Proceed With Caution Weak ยท 45/100

Alnylam Pharmaceuticals Inc (Healthcare) ยท $148.30 ยท Analysis generated Nov 20, 2026 ยท Data as of market close Nov 20 ยท Market closed โ€” data may be from last trading day
This strategy is NOT recommended for ALNY right now
Score 45/100. The technical signals do not support selling covered calls on ALNY at this time. RSI at 30 โ€” oversold, not ideal for selling calls. IV -13% vs avg โ€” premiums near average, acceptable. ADX at 35 โ€” strong trend, stock may run past strike. Check back when conditions improve, or consider a different strategy.

Quick Take

ALNY is trading at $148.30 with RSI at 30 (oversold territory). Options IV is at 52% โ€” 13% below its 30-day average of 59%. Neither RSI nor IV strongly favor selling calls right now. Consider waiting for better conditions or using a different strategy.

Technical Signals

RSI (14)
30
IV Today
51.5%
IV vs 30d Avg
-13%
MACD
bullish
ADX
35
MFI
48

The Setup

ALNY Covered Call

LONG STOCK
100 shares @ $148.3
SHORT CALL
$160 Jan '27 ยท $7.71/sh
Net Cost
$14,059
Max Profit
+$1,941
Break-even
$140.59
Projected P&L at Target
+$1,941 (13.8%)
P&L at Expiry Now $148 $104 $148 $193

P&L Scenarios

What happens at different ALNY prices by expiry:

ALNY Price Today +3d (Nov 24) +7d (Nov 28) Dec 9 Dec 27 Jan 15 (exp)
$119 (-20%) -$2,285 -$2,274 -$2,261 -$2,228 -$2,198 -$2,195
$126 (-15%) -$1,628 -$1,612 -$1,591 -$1,535 -$1,467 -$1,453
$133 (-10%) -$1,023 -$1,000 -$970 -$886 -$761 -$712
$141 (-5%) -$478 -$449 -$410 -$298 -$103 +$29
$145 (-2%) -$183 -$151 -$107 +$20 +$255 +$474
$148 (0%) โ† now -$0 +$34 +$80 +$216 +$476 +$771
$151 (+2%) +$171 +$207 +$255 +$398 +$679 +$1,068
$156 (+5%) +$407 +$444 +$495 +$646 +$949 +$1,513
$160 (+8%) โ† target +$616 +$654 +$707 +$862 +$1,177 +$1,941
$163 (+10%) +$743 +$781 +$834 +$991 +$1,306 +$1,941
$171 (+15%) +$1,015 +$1,052 +$1,104 +$1,256 +$1,553 +$1,941
$178 (+20%) +$1,229 +$1,264 +$1,313 +$1,454 +$1,711 +$1,941

Why This Strategy, Why Now

  • RSI at 30 โ€” oversold, not ideal for selling calls
  • IV -13% vs avg โ€” premiums near average, acceptable
  • MACD bullish โ€” stock has upward momentum
  • ADX at 35 โ€” strong trend, stock may run past strike
  • No squeeze โ€” no imminent breakout

Key Risks

ALNY has bullish momentum (MACD). If a positive catalyst emerges (earnings beat, product launch), the stock could gap past your strike. Consider rolling the call up if ALNY approaches the strike before expiry.
ADX at 35 indicates a moderately strong trend. In trending markets, covered calls cap your upside too early. Use a higher strike to leave more room.